University Hospital, Montpellier: Arthritis, Rheumatoid trials
The registry lists 26 Arthritis, Rheumatoid studies with University Hospital, Montpellier as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 3 2No phase 24(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Immun4Cure Cohort of Autoimmune DiseasesRecruitingNCT07515638
- National Cohort of Subjects at Risk of Developing Rheumatoid ArthritisRecruitingNCT06876064
- Gut Microbiota: a Player in Chronic Pain in Patients With Rheumatoid Arthritis?RecruitingNCT05822856
- Study of the Functional Status Neutrophils in Rheumatoid Arthritis Patients to Identify New Biomarkers of Response to Anti-TNFalpha TherapyRecruitingNCT05802719Not applicable
- Efficacy of a Sequential Treatment Strategy in Rheumatoid ArthritisRecruitingNCT05428488Phase 3
- Effect of Controlling Environmental Risk Factors in Established RARecruitingNCT05198271Not applicable
- Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitorRecruitingNCT04530305
- Purify Antigen-specific B Cells From Patients With Rheumatoid ArthritisStatus unknownNCT05203952
- Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis PatientsCompletedNCT04880720
- IL-6 as a Biomarker for Personalized Treatment of PRCompletedNCT04779983
- Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis PatientsCompletedNCT04679272
- Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic DiseasesCompletedNCT04655612
- COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive DrugsCompletedNCT04530682
- Fibres Supplementation in Rheumatoid ArthritisStatus unknownNCT04421313Not applicable
- COVID-SErology in Rheumatoid Arthritis (COVID-19)CompletedNCT04407559
- Information and Acceptability of BiosimilarsStatus unknownNCT04321291Not applicable
- JAKPOT (JAK Inhibitors and Predictors of Outcome in RheumaToid Arthritis)TerminatedNCT04084223Not applicable
- Effect of the Inhibitors of the Way JAK-STAT on Regulatory B CellsTerminatedNCT03755297Not applicable
- Characterization of Regulatory T Lymphocytes in the Synovial Fluid of Patients Affected by Rheumatoid Arthritis.TerminatedNCT03293667Not applicable
- Use of Remote Monitoring by Smartphone in the Care Management of Patients With Rheumatoid ArthritisTerminatedNCT03005925Not applicable
- Role of Ultrasound for Evaluating Rheumatoid Arthritis in RemissionCompletedNCT02618954Not applicable
- Characterization of Breg CellsCompletedNCT02615951Not applicable
- Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis PatientsCompletedNCT02547493Not applicable
- Digitized Grip StrengthStatus unknownNCT02197507Not applicable
- VACcination In Methotrexate Treated Rheumatoid Arthritis PatientsCompletedNCT01942174Phase 3
- Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic TreatmentsStatus unknownNCT01642706